| MRI characteristics of neuromyelitis optica spectrum disorder: an international update HJ Kim, F Paul, MA Lana-Peixoto, S Tenembaum, N Asgari, J Palace, ... Neurology 84 (11), 1165-1173, 2015 | 600 | 2015 |
| Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial BAC Cree, JL Bennett, HJ Kim, BG Weinshenker, SJ Pittock, ... The Lancet 394 (10206), 1352-1363, 2019 | 555 | 2019 |
| Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study A Cobo-Calvo, A Ruiz, E Maillart, B Audoin, H Zephir, B Bourre, J Ciron, ... Neurology 90 (21), e1858-e1869, 2018 | 437 | 2018 |
| Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ... Multiple Sclerosis Journal 21 (8), 1013-1024, 2015 | 372 | 2015 |
| Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody–associated disease Y Hacohen, YY Wong, C Lechner, M Jurynczyk, S Wright, B Konuskan, ... JAMA neurology 75 (4), 478-487, 2018 | 363 | 2018 |
| Treatment of neuromyelitis optica: review and recommendations DJ Kimbrough, K Fujihara, A Jacob, MA Lana-Peixoto, MI Leite, M Levy, ... Multiple sclerosis and related disorders 1 (4), 180-187, 2012 | 353 | 2012 |
| Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria B Banwell, JL Bennett, R Marignier, HJ Kim, F Brilot, EP Flanagan, ... The Lancet Neurology 22 (3), 268-282, 2023 | 326 | 2023 |
| Myelin-oligodendrocyte glycoprotein antibody-associated disease R Marignier, Y Hacohen, A Cobo-Calvo, AK Pröbstel, O Aktas, ... The Lancet Neurology 20 (9), 762-772, 2021 | 313 | 2021 |
| The investigation of acute optic neuritis: a review and proposed protocol A Petzold, MP Wattjes, F Costello, J Flores-Rivera, CL Fraser, K Fujihara, ... Nature Reviews Neurology 10 (8), 447-458, 2014 | 295 | 2014 |
| Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide JY Hor, N Asgari, I Nakashima, SA Broadley, MI Leite, N Kissani, A Jacob, ... Frontiers in neurology 11, 501, 2020 | 278 | 2020 |
| Neuromyelitis optica in France: a multicenter study of 125 patients N Collongues, R Marignier, H Zephir, C Papeix, F Blanc, C Ritleng, ... Neurology 74 (9), 736-742, 2010 | 257 | 2010 |
| Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica P Waters, M Reindl, A Saiz, K Schanda, F Tuller, V Kral, P Nytrova, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (9), 1005-1015, 2016 | 251 | 2016 |
| Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury R Marignier, A Nicolle, C Watrin, M Touret, S Cavagna, M Varrin-Doyer, ... Brain 133 (9), 2578-2591, 2010 | 204 | 2010 |
| Aquaporin-4 antibody–negative neuromyelitis optica: distinct assay sensitivity–dependent entity R Marignier, R Bernard-Valnet, P Giraudon, N Collongues, C Papeix, ... Neurology 80 (24), 2194-2200, 2013 | 202 | 2013 |
| Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis S Jarius, J Frederikson, P Waters, F Paul, G Akman-Demir, R Marignier, ... Journal of the neurological sciences 298 (1-2), 158-162, 2010 | 187 | 2010 |
| Worldwide incidence and prevalence of neuromyelitis optica: a systematic review V Papp, M Magyari, O Aktas, T Berger, SA Broadley, P Cabre, A Jacob, ... Neurology 96 (2), 59-77, 2021 | 163 | 2021 |
| NMO-IgG and Devic's neuromyelitis optica: a French experience R Marignier, J De Sèze, S Vukusic, F Durand-Dubief, H Zéphir, ... Multiple Sclerosis Journal 14 (4), 440-445, 2008 | 143 | 2008 |
| Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody–associated disease A Cobo‐Calvo, A Ruiz, F Rollot, G Arrambide, R Deschamps, E Maillart, ... Annals of neurology 89 (1), 30-41, 2021 | 140 | 2021 |
| Is neuromyelitis optica associated with human leukocyte antigen? H Zephir, I Fajardy, O Outteryck, F Blanc, N Roger, M Fleury, G Rudolf, ... Multiple Sclerosis Journal 15 (5), 571-579, 2009 | 138 | 2009 |
| Multiple sclerosis and pregnancy in the'treatment era' S Vukusic, R Marignier Nature Reviews Neurology 11 (5), 280-289, 2015 | 137 | 2015 |
